Literature DB >> 7778033

Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus.

M F Vaezi1, J E Richter.   

Abstract

BACKGROUND: The role of acid and duodenogastroesophageal reflux (DGER) in the development of complications in Barrett's esophagus is controversial. We characterized the esophageal reflux constituents in patients with and without complications of Barrett's esophagus.
METHODS: Using a new fiber-optic system we studied 12 normal subjects (six male; mean age, 46 years) and 20 patients with Barrett's esophagus (17 male; mean age, 58 years), nine with uncomplicated (seven male; mean age, 55 years) and 11 with complicated Barrett's esophagus (seven with stricture, two with ulcer, and two with dysplasia; 10 male; mean age, 61 years). Fasting gastric bile acid concentrations were measured. Twenty-four-hour ambulatory acid and bilirubin measurements were obtained with the fiber-optic system by using a glass electrode and fiber-optic sensor. The data were then analyzed for percent total time pH < 4 and > 7 and bilirubin absorbance > 0.14%.
RESULTS: Percent times pH < 4, bilirubin absorbance > 0.14%, and fasting gastric bile acid concentrations were significantly greater in patients with complicated Barrett's esophagus compared with patients with uncomplicated Barrett's esophagus with both being higher than the controls. Acid reflux paralleled bile reflux in the two Barrett's esophagus groups (r = 0.44, p < 0.05), but percent time pH > 7 did not differentiate between the two groups.
CONCLUSIONS: (1) Patients with complicated Barrett's esophagus reflux significantly greater amounts of both acid and duodenal contents than patients with uncomplicated Barrett's esophagus. (2) Complications in Barrett's esophagus may be due to synergism between acid and bile rather than either constituent alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7778033     DOI: 10.1016/s0039-6060(95)80015-8

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  36 in total

1.  Barrett's oesophagus and proton pump inhibitors: a pathological perspective.

Authors:  N A Shepherd
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

2.  Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus.

Authors:  H Tigges; K H Fuchs; J Maroske; M Fein; S M Freys; J Müller; A Thiede
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

3.  Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats.

Authors:  Koji Nishijima; Koichi Miwa; Tomoharu Miyashita; Shinichi Kinami; Itasu Ninomiya; Sachio Fushida; Takashi Fujimura; Takanori Hattori
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

4.  Laparoscopic Nissen repair: indications, techniques and long-term benefits.

Authors:  K H Fuchs; W Breithaupt; M Fein; J Maroske; I Hammer
Journal:  Langenbecks Arch Surg       Date:  2004-07-03       Impact factor: 3.445

Review 5.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

6.  Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux.

Authors:  S Oberg; M P Ritter; P F Crookes; M Fein; R J Mason; M Gadensytätter; C G Brenner; J H Peters; T R DeMeester
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.452

7.  Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus.

Authors:  R E Marshall; A Anggiansah; D K Manifold; W A Owen; W J Owen
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

8.  Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance.

Authors:  D Sifrim; J Silny; R H Holloway; J J Janssens
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

9.  Laparoscopic surgery for gastro-oesophageal reflux disease.

Authors:  D Alderson; C R Welbourn
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

10.  Gastric juice protects against the development of esophageal adenocarcinoma in the rat.

Authors:  A P Ireland; J H Peters; T C Smyrk; T R DeMeester; G W Clark; S S Mirvish; T E Adrian
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.